David T. Rubin, MD, on Dysplasia and Colorectal Cancer Surveillance in IBD

In this video, David T. Rubin, MD, from the University of Chicago, discusses the importance of screening and surveillance for dysplasia and colorectal cancer among patients with inflammatory bowel disease (IBD), the ideal time of the first colonoscopy, and the patient factors that determine the frequency of screenings.

David T. Rubin, MD, is a professor of medicine at the University of Chicago in Chicago, Illinois.

 

Submit Feedback

Name